CoreWeave stock (CRWV) jumps 11% as filing shows looser loan covenants ahead of Monday

CoreWeave stock (CRWV) jumps 11% as filing shows looser loan covenants ahead of Monday

NEW YORK, Jan 4, 2026, 10:53 ET — Market closed

  • CoreWeave shares closed up 10.8% at $79.32 on Friday, finishing near the $80 level.
  • A late-day SEC filing showed the AI cloud firm amended its DDTL 3.0 credit agreement to ease liquidity and covenant terms.
  • Insider filings also reported share sales by CEO Michael Intrator and two other executives tied largely to stock-unit settlements and tax withholding.

CoreWeave said in an SEC filing after Friday’s close that it amended a key credit agreement, easing liquidity and covenant terms tied to a major secured loan facility. Shares of the AI cloud provider ended Friday up 10.8% at $79.32.

The changes matter because CoreWeave relies heavily on debt financing to buy the servers and infrastructure needed to deliver AI computing capacity. Its DDTL 3.0 facility — a delayed-draw term loan that lets a borrower tap funds in stages — was set up to finance capital expenditures including GPU servers for a customer contract. SEC

CoreWeave said the amendment was meant to align the facility with the “timing of deliveries” it discussed on its earnings call for the quarter ended Sept. 30, 2025. That puts fresh focus on execution risk in large AI data center buildouts, where delivery timing can swing cash needs and covenant headroom.

Under the amendment, CoreWeave lowered a minimum liquidity requirement to $100 million for monthly payment dates from March 1, 2026 through April 2026, the filing showed. It also pushed back the first test date for its debt service coverage ratio — a common measure of cash flow relative to debt payments — to Oct. 31, 2027.

The amendment also postponed initial testing of a “contract realization ratio” covenant to Feb. 28, 2026. In the loan’s original disclosure, CoreWeave described that ratio as comparing actual amounts billed or received under the customer contract over the prior three months to projected contracted cash flows for that period. SEC

CoreWeave added flexibility through expanded “equity cure” rights — a provision that allows a borrower to inject equity to remedy a covenant breach — permitting unlimited cures before Oct. 28, 2026, the filing said. After that date, cures are limited to no more than three consecutive months in any four-month period.

The company said it plans to file the full text of the amendment as an exhibit to its annual report on Form 10-K for the year ended Dec. 31, 2025.

Separate Form 4 filings on Friday reported insider transactions dated Dec. 31, including sales tied to restricted stock unit settlements and tax withholding. CEO Michael Intrator reported sales that included transactions marked as made under a Rule 10b5-1 plan, while executives Brian Venturo and Brannin McBee reported sales at roughly $72–$73 a share connected to tax obligations, the filings showed.

CoreWeave’s sharp move on Friday came as chip stocks helped lift U.S. equities at the start of 2026, with the Philadelphia SE Semiconductor index up 4%, Reuters reported. Joe Mazzola, head of trading & derivatives strategy at Charles Schwab, said investors are “a little bit more conscious” about valuations for some AI-linked names.

Broader gains in Nvidia and Intel supported risk appetite, even as several mega-cap tech stocks fell and capped index gains, Reuters said. The backdrop has kept trading in AI infrastructure names sensitive to shifts in rate expectations and sentiment on high-growth valuations.

But looser covenants can also read as lenders giving a fast-growing, capital-intensive borrower more runway — and investors have been alert to execution risk. CoreWeave cut its annual revenue forecast in November after a delay at a data center partner, and Barclays analysts called it an early sign of operational risk surfacing in the young AI infrastructure sector, Reuters reported. Reuters

With U.S. markets closed over the weekend, traders will watch how CRWV reacts when regular trading resumes on Monday, Jan. 5, and whether the stock can hold above the mid-$70s after Friday’s $72.95–$81.11 range. The next macro catalysts include ISM manufacturing data on Jan. 5 and ISM services on Jan. 7, followed by the U.S. December employment report on Friday, Jan. 9 at 8:30 a.m. ET; BMO Capital Markets expects a 50,000 payroll gain and a 4.6% unemployment rate, Kiplinger reported.

Stock Market Today

No summaries found on the roundup post.

Lam Research stock today: LRCX jumps 8% on Citi list as chip-equipment rally builds
Previous Story

Lam Research stock today: LRCX jumps 8% on Citi list as chip-equipment rally builds

Liquidia stock heads into Monday after 9% slide and spike in bearish put options
Next Story

Liquidia stock heads into Monday after 9% slide and spike in bearish put options

Go toTop